Literature DB >> 10725732

Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages.

M Miettinen1, A Lehtonen, I Julkunen, S Matikainen.   

Abstract

Gram-positive bacteria induce the production of several cytokines in human leukocytes. The molecular mechanisms involved in Gram-positive bacteria-induced cytokine production have been poorly characterized. In this work we demonstrate that both nonpathogenic Lactobacillus rhamnosus GG and pathogenic Streptococcus pyogenes (group A streptococci) induce NF-kappa B and STAT DNA-binding activity in human primary macrophages as analyzed by EMSA. NF-kappa B activation was rapid and was not inhibited by a protein synthesis inhibitor cycloheximide, suggesting that these bacteria could directly activate NF-kappa B. STAT1, STAT3, and IFN regulatory factor-1 DNA binding was induced by both bacteria with delayed kinetics compared with NF-kappa B. In addition, streptococci induced the formation of IFN-alpha-specific transcription factor complex and IFN-stimulated gene factor-3 (ISGF3). STAT1 and STAT3 activation and ISGF3 complex formation were inhibited by cycloheximide or by neutralization with IFN-alpha/beta-specific Abs. Streptococci were more potent than lactobacilli in inducing STAT1, ISGF3, and IFN regulatory factor-1 DNA binding. Accordingly, only streptococci induced IFN-alpha production. The activation of the IFN-alpha signaling pathway by streptococci could play a role in the pathogenesis of these bacteria. These results indicate that extracellular Gram-positive bacteria activate transcription factors involved in cytokine signaling by two mechanisms: directly, leading to NF-kappa B activation, and indirectly via cytokines, leading to STAT activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725732     DOI: 10.4049/jimmunol.164.7.3733

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors:  N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus.

Authors:  Jinghua Wu; Cuiqing Ma; Haixin Wang; Shuhui Wu; Gao Xue; Xinli Shi; Zhang Song; Lin Wei
Journal:  Cell Mol Immunol       Date:  2014-11-17       Impact factor: 11.530

Review 3.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

4.  Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.

Authors:  Ulf Helwig; Karen M Lammers; Fernando Rizzello; Patricia Brigidi; Verena Rohleder; Elisabetta Caramelli; Paolo Gionchetti; Juergen Schrezenmeir; Ulrich R Foelsch; Stefan Schreiber; Massimo Campieri
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 5.  Genes and molecules of lactobacilli supporting probiotic action.

Authors:  Sarah Lebeer; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 6.  Probiotics-host communication: Modulation of signaling pathways in the intestine.

Authors:  Carissa M Thomas; James Versalovic
Journal:  Gut Microbes       Date:  2010 May-Jun

7.  Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid.

Authors:  Riku Korhonen; Riitta Korpela; Eeva Moilanen
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

8.  Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression.

Authors:  Donglai Ma; Paul Forsythe; John Bienenstock
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 9.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

10.  Role of macrophages in host resistance to group A streptococci.

Authors:  Oliver Goldmann; Manfred Rohde; Gursharan Singh Chhatwal; Eva Medina
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.